GlassScriptPhysician profile
Jeffrey P Broadbent
NPI 1336434661
$3,781.33
in general payments reported to CMS, 2019-2025
9 companies · $313 in 2025
The $313 reported for 2025 was more than what 84% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.81 · 2021: $84.35 · 2022: $12.42 · 2023: $2,033 · 2024: $1,321 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,849 · Education: $1,038 · Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,848.55 |
| Education | $1,037.50 |
| Food and Beverage | $780.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,012.95 | 2021-2024 | Implant Dentistry, Ossix Plus |
| Ultradent Products INC | $1,012.69 | 2023-2025 | Opalescence |
| Premier Dental Products Company | $858.10 | 2024 | Premierair H6/H7, Big Easy Insert #10 Universal 25k |
| Patterson Companies, INC. | $814.87 | 2021-2023 | |
| Envista Holdings Corporation | $22.41 | 2025 | Maxcem Elite |
| Nobel Biocare USA | $17.81 | 2019 | |
| Solventum Corporation | $15.53 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Colgate Oral Pharmaceuticals, INC. | $14.55 | 2024 | |
| Voco America INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Broadbent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.